12
Participants
Start Date
March 31, 2013
Primary Completion Date
June 30, 2014
Study Completion Date
December 31, 2014
Closed-loop blood glucose control
The InPatient Closed Loop Device is made up of the three components; the Abbott FreeStyle Navigator subcutaneous continuous glucose monitor, the Symbiq insulin-dextrose infusion system, and the control algorithm. In this feasibility trial we will study 6 insulin-sensitive subjects with type 1 diabetes and 6 subjects with type 2 diabetes and a high insulin requirement (3 with total daily dose from 1-1.9 u/kg and 3 with total daily dose \> 2 u/kg).
MGH Diabetes Research Center, Boston
Boston University
OTHER
Massachusetts General Hospital
OTHER